Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

JYNT vs USPH vs ENSG vs ACHC vs SEM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
JYNT
The Joint Corp.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$124M
5Y Perf.-42.6%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-20.4%
ENSG
The Ensign Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$10.18B
5Y Perf.+298.7%
ACHC
Acadia Healthcare Company, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$2.25B
5Y Perf.-14.5%
SEM
Select Medical Holdings Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$2.04B
5Y Perf.+89.2%

JYNT vs USPH vs ENSG vs ACHC vs SEM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
JYNT logoJYNT
USPH logoUSPH
ENSG logoENSG
ACHC logoACHC
SEM logoSEM
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$124M$897M$10.18B$2.25B$2.04B
Revenue (TTM)$57M$695M$5.27B$3.37B$5.52B
Net Income (TTM)$3M$11M$363M$-1.11B$134M
Gross Margin78.5%22.0%15.2%56.2%10.6%
Operating Margin1.1%12.2%8.5%11.7%5.8%
Forward P/E44.9x20.6x23.2x16.4x13.1x
Total Debt$2M$426M$4.15B$2.65B$3.70B
Cash & Equiv.$24M$36M$504M$133M$27M

JYNT vs USPH vs ENSG vs ACHC vs SEMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

JYNT
USPH
ENSG
ACHC
SEM
StockMay 20May 26Return
The Joint Corp. (JYNT)10057.4-42.6%
U.S. Physical Thera… (USPH)10079.6-20.4%
The Ensign Group, I… (ENSG)100398.7+298.7%
Acadia Healthcare C… (ACHC)10085.5-14.5%
Select Medical Hold… (SEM)100189.2+89.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: JYNT vs USPH vs ENSG vs ACHC vs SEM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ENSG leads in 5 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. U.S. Physical Therapy, Inc. is the stronger pick specifically for dividend income and shareholder returns. SEM also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
JYNT
The Joint Corp.
The Healthcare Pick

JYNT lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
USPH
U.S. Physical Therapy, Inc.
The Income Pick

USPH is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 5 yrs, beta 0.93, yield 3.1%
  • 3.1% yield, 5-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
Best for: income & stability
ENSG
The Ensign Group, Inc.
The Growth Play

ENSG carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
  • 7.5% 10Y total return vs SEM's 158.5%
  • Lower volatility, beta 0.42, current ratio 1.42x
  • Beta 0.42, yield 0.1%, current ratio 1.42x
Best for: growth exposure and long-term compounding
ACHC
Acadia Healthcare Company, Inc.
The Healthcare Pick

Among these 5 stocks, ACHC doesn't own a clear edge in any measured category.

Best for: healthcare exposure
SEM
Select Medical Holdings Corporation
The Value Play

SEM ranks third and is worth considering specifically for value.

  • Lower P/E (13.1x vs 16.4x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthENSG logoENSG18.7% revenue growth vs ACHC's 5.0%
ValueSEM logoSEMLower P/E (13.1x vs 16.4x)
Quality / MarginsENSG logoENSG6.9% margin vs ACHC's -32.8%
Stability / SafetyENSG logoENSGBeta 0.42 vs JYNT's 0.98
DividendsUSPH logoUSPH3.1% yield, 5-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
Momentum (1Y)ENSG logoENSG+27.5% vs USPH's -14.3%
Efficiency (ROA)ENSG logoENSG6.8% ROA vs ACHC's -18.6%, ROIC 7.0% vs 5.9%

JYNT vs USPH vs ENSG vs ACHC vs SEM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

JYNTThe Joint Corp.
FY 2025
Royalty
60.5%$33M
Advertising
19.0%$10M
Technology Service
11.0%$6M
Franchise
6.1%$3M
Product and Service, Other
3.3%$2M
USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
ENSGThe Ensign Group, Inc.
FY 2025
Skilled Services Segment
97.4%$4.8B
Standard Bearer Segment
2.6%$127M
ACHCAcadia Healthcare Company, Inc.
FY 2025
United States Facilities
100.0%$3.3B
SEMSelect Medical Holdings Corporation
FY 2025
Health Care, Patient Service, Non-Medicare
61.5%$3.4B
Health Care, Patient Service, Medicare
28.6%$1.6B
Service, Other
9.9%$538M

JYNT vs USPH vs ENSG vs ACHC vs SEM — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJYNTLAGGINGACHC

Income & Cash Flow (Last 12 Months)

Evenly matched — JYNT and USPH and ENSG each lead in 2 of 6 comparable metrics.

SEM is the larger business by revenue, generating $5.5B annually — 97.5x JYNT's $57M. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…
RevenueTrailing 12 months$57M$695M$5.3B$3.4B$5.5B
EBITDAEarnings before interest/tax$2M$107M$558M$588M$465M
Net IncomeAfter-tax profit$3M$11M$363M-$1.1B$134M
Free Cash FlowCash after capex$3M$67M$406M-$215M$117M
Gross MarginGross profit ÷ Revenue+78.5%+22.0%+15.2%+56.2%+10.6%
Operating MarginEBIT ÷ Revenue+1.1%+12.2%+8.5%+11.7%+5.8%
Net MarginNet income ÷ Revenue+5.7%+1.5%+6.9%-32.8%+2.4%
FCF MarginFCF ÷ Revenue+4.7%+9.6%+7.7%-6.4%+2.1%
Rev. Growth (YoY)Latest quarter vs prior year+13.3%+7.7%+18.4%+7.6%+5.0%
EPS Growth (YoY)Latest quarter vs prior year+71.4%-115.0%+21.9%-49.8%-18.2%
Evenly matched — JYNT and USPH and ENSG each lead in 2 of 6 comparable metrics.

Valuation Metrics

SEM leads this category, winning 4 of 6 comparable metrics.

At 13.9x trailing earnings, SEM trades at a 69% valuation discount to JYNT's 45.6x P/E. On an enterprise value basis, ACHC's 8.3x EV/EBITDA is more attractive than JYNT's 126.9x.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…
Market CapShares × price$124M$897M$10.2B$2.3B$2.0B
Enterprise ValueMkt cap + debt − cash$103M$1.3B$13.8B$4.8B$5.7B
Trailing P/EPrice ÷ TTM EPS45.63x41.55x29.85x-2.01x13.93x
Forward P/EPrice ÷ next-FY EPS est.44.85x20.63x23.19x16.42x13.06x
PEG RatioP/E ÷ EPS growth rate2.16x
EV / EBITDAEnterprise value multiple126.93x12.52x25.71x8.27x12.04x
Price / SalesMarket cap ÷ Revenue2.26x1.15x2.01x0.68x0.37x
Price / BookPrice ÷ Book value/share8.70x1.16x4.59x1.04x1.00x
Price / FCFMarket cap ÷ FCF370.99x14.71x27.46x5.33x
SEM leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

JYNT leads this category, winning 5 of 9 comparable metrics.

JYNT delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-41 for ACHC. JYNT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), JYNT scores 6/9 vs SEM's 5/9, reflecting solid financial health.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…
ROE (TTM)Return on equity+16.9%+1.4%+16.6%-40.9%+6.6%
ROA (TTM)Return on assets+5.0%+0.9%+6.8%-18.6%+2.3%
ROICReturn on invested capital+5.6%+7.0%+5.9%+4.8%
ROCEReturn on capital employed-2.9%+7.6%+10.2%+7.5%+7.0%
Piotroski ScoreFundamental quality 0–965555
Debt / EquityFinancial leverage0.13x0.55x1.86x1.24x1.82x
Net DebtTotal debt minus cash-$22M$390M$3.7B$2.5B$3.7B
Cash & Equiv.Liquid assets$24M$36M$504M$133M$27M
Total DebtShort + long-term debt$2M$426M$4.2B$2.7B$3.7B
Interest CoverageEBIT ÷ Interest expense15.42x88.33x-5.99x4.41x
JYNT leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ENSG leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $1,608 for JYNT. Over the past 12 months, ENSG leads with a +27.5% total return vs USPH's -14.3%. The 3-year compound annual growth rate (CAGR) favors ENSG at 23.6% vs ACHC's -29.2% — a key indicator of consistent wealth creation.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…
YTD ReturnYear-to-date-2.0%-24.6%+0.3%+71.2%+11.4%
1-Year ReturnPast 12 months-12.8%-14.3%+27.5%+1.2%+11.1%
3-Year ReturnCumulative with dividends-41.0%-43.7%+88.9%-64.5%+7.4%
5-Year ReturnCumulative with dividends-83.9%-43.4%+103.2%-61.8%-11.1%
10-Year ReturnCumulative with dividends+191.9%+22.6%+752.0%-58.5%+158.5%
CAGR (3Y)Annualised 3-year return-16.1%-17.4%+23.6%-29.2%+2.4%
ENSG leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ENSG and SEM each lead in 1 of 2 comparable metrics.

ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than JYNT's 0.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SEM currently trades 96.8% from its 52-week high vs USPH's 63.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…
Beta (5Y)Sensitivity to S&P 5000.98x0.93x0.42x0.84x0.46x
52-Week HighHighest price in past year$13.47$93.50$218.00$30.20$16.99
52-Week LowLowest price in past year$7.50$58.55$133.81$11.43$11.65
% of 52W HighCurrent price vs 52-week peak+64.4%+63.1%+80.0%+81.0%+96.8%
RSI (14)Momentum oscillator 0–10049.346.123.346.260.9
Avg Volume (50D)Average daily shares traded57K171K358K3.1M2.1M
Evenly matched — ENSG and SEM each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — USPH and ENSG each lead in 1 of 2 comparable metrics.

Analyst consensus: JYNT as "Buy", USPH as "Buy", ENSG as "Buy", ACHC as "Buy", SEM as "Hold". Consensus price targets imply 130.7% upside for JYNT (target: $20) vs -3.9% for ACHC (target: $24). For income investors, USPH offers the higher dividend yield at 3.06% vs ENSG's 0.14%.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyHold
Price TargetConsensus 12-month target$20.00$102.00$222.33$23.50$18.00
# AnalystsCovering analysts812132513
Dividend YieldAnnual dividend ÷ price+3.1%+0.1%+1.5%
Dividend StreakConsecutive years of raises51210
Dividend / ShareAnnual DPS$1.80$0.24$0.25
Buyback YieldShare repurchases ÷ mkt cap+9.1%+0.6%+0.2%+2.2%+4.9%
Evenly matched — USPH and ENSG each lead in 1 of 2 comparable metrics.
Key Takeaway

SEM leads in 1 of 6 categories (Valuation Metrics). JYNT leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallThe Joint Corp. (JYNT)Leads 1 of 6 categories
Loading custom metrics...

JYNT vs USPH vs ENSG vs ACHC vs SEM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is JYNT or USPH or ENSG or ACHC or SEM a better buy right now?

For growth investors, The Ensign Group, Inc.

(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate The Joint Corp. (JYNT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — JYNT or USPH or ENSG or ACHC or SEM?

On trailing P/E, Select Medical Holdings Corporation (SEM) is the cheapest at 13.

9x versus The Joint Corp. at 45. 6x. On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13. 1x.

03

Which is the better long-term investment — JYNT or USPH or ENSG or ACHC or SEM?

Over the past 5 years, The Ensign Group, Inc.

(ENSG) delivered a total return of +103. 2%, compared to -83. 9% for The Joint Corp. (JYNT). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus ACHC's -58. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — JYNT or USPH or ENSG or ACHC or SEM?

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 42β versus The Joint Corp. 's 0. 98β — meaning JYNT is approximately 133% more volatile than ENSG relative to the S&P 500. On balance sheet safety, The Joint Corp. (JYNT) carries a lower debt/equity ratio of 13% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — JYNT or USPH or ENSG or ACHC or SEM?

By revenue growth (latest reported year), The Ensign Group, Inc.

(ENSG) is pulling ahead at 18. 7% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: The Joint Corp. grew EPS 133. 9% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — JYNT or USPH or ENSG or ACHC or SEM?

The Ensign Group, Inc.

(ENSG) is the more profitable company, earning 6. 8% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACHC leads at 11. 7% versus -1. 6% for JYNT. At the gross margin level — before operating expenses — JYNT leads at 76. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is JYNT or USPH or ENSG or ACHC or SEM more undervalued right now?

On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.

1x forward P/E versus 44. 9x for The Joint Corp. — 31. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JYNT: 130. 7% to $20. 00.

08

Which pays a better dividend — JYNT or USPH or ENSG or ACHC or SEM?

In this comparison, USPH (3.

1% yield), SEM (1. 5% yield), ENSG (0. 1% yield) pay a dividend. JYNT, ACHC do not pay a meaningful dividend and should not be held primarily for income.

09

Is JYNT or USPH or ENSG or ACHC or SEM better for a retirement portfolio?

For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

46), 1. 5% yield, +158. 5% 10Y return). Both have compounded well over 10 years (SEM: +158. 5%, ACHC: -58. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between JYNT and USPH and ENSG and ACHC and SEM?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: JYNT is a small-cap quality compounder stock; USPH is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; ACHC is a small-cap quality compounder stock; SEM is a small-cap deep-value stock. USPH, SEM pay a dividend while JYNT, ENSG, ACHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

JYNT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 5%
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

ENSG

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 5%
Run This Screen
Stocks Like

ACHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Stocks Like

SEM

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform JYNT and USPH and ENSG and ACHC and SEM on the metrics below

Revenue Growth>
%
(JYNT: 13.3% · USPH: 7.7%)
P/E Ratio<
x
(JYNT: 45.6x · USPH: 41.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.